Myocarditis in the pediatric population: A review.
guidelines
myocarditis
pediatrics
Journal
Congenital heart disease
ISSN: 1747-0803
Titre abrégé: Congenit Heart Dis
Pays: United States
ID NLM: 101256510
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
25
06
2019
revised:
01
08
2019
accepted:
02
08
2019
pubmed:
23
8
2019
medline:
25
2
2020
entrez:
22
8
2019
Statut:
ppublish
Résumé
Myocarditis has a variable clinical presentation and there is still debate regarding accurate diagnostic criteria. Adding to the controversy surrounding this diagnosis, there is no clear consensus for the treatment or ongoing follow-up of patients with myocarditis. All of this makes the diagnosis and management of myocarditis a particular challenge in the pediatric population. Furthermore, the literature with respect to this topic is dynamic and ever-changing. In this review article, we aim to review and summarize the common clinical presentations of myocarditis, along with the latest recommendations for diagnostic criteria, treatment, and follow-up of patients with myocarditis.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
868-877Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841-842.
Bohn D. Acute viral myocarditis in children: guidelines. Pediatr Crit Care Med. 2006;S1-S24.
Kühl U, Schultheiss H. Myocarditis in children. Heart Fail Clin. 2010;483-496.
Levine M, Klugman D, Teach S. Update on myocarditis in children. Curr Opin Pediatr. 2010;22:78-283.
Wakafuji S, Okada R. Twenty year autopsy statistics of myocarditis incidence in Japan. Jpn Circ J. 1986;50:1288-1293.
Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust. 2004;180:110-112.
Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The myocarditis treatment trial investigators. N Engl J Med. 1995;333:269-275.
Magnani J, Danik H, Dec GJ, DiSalvo T. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am J Heart. 2006;151:465-470.
Freedman S, Haladyn J, Floh A, Kirsh J, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007;120:278-1285.
Chang Y, Chao H, Hsia S, Yan D. Myocarditis presenting as gastritis in children. Pediatr Emerg Care. 2006;22:439-440.
Saji T, Matsuura H, Hasegawa K, et al. Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children. Circ J. 2012;76:1222-1228.
Kane D, Fulton D, Saleeb S, Zhou J, Lock J, Geggel R. Needles in hay: chest pain as the presenting symptom in children with serious underlying cardiac pathology. Congenit Heart Dis. 2010;5:366-373.
Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114:1581-1590.
Maron B, Doerer J, Haas T, Tierney D, Mueller F. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-200. Circulation. 2009;119:1085-1092.
Rajs J, Hammarquist F. Sudden infant death in Stockholm. A forensic pathology study covering ten years. Acta Paediatr Scand. 1988;77:812-820.
Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116:2216-2233.
Batra A, Epstein D, Silka M. The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol. 2003;24:495-497.
Canter CE, Simpson KE. Diagnosis and treatment of myocarditis in children in the current era. Circulation. 2014;129:115-128.
Chien S, Liang C, Lin I, Lin Y, Huang C. Myocarditis complicated by complete atrioventricular block: nine years' experience in a medical center. Pediatr Neonatol. 2008;49:218-222.
Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59:779-792.
Lippi G, Salvagno G, Guidi G. Cardiac troponins in pediatric myocarditis. Pediatrics. 2008;121:864.
Smith S, Ladenson J, Mason J, Jaffe A. Elevations of cardiac troponin I associated with myocarditis. Circulation. 1997;95:163-168.
Elamm C, Fairweather D, Cooper L. Pathogenesis and diagnosis of myocarditis. Heart. 2012;98:835-840.
Koulouri S, Acherman R, Wong P, Chan L, Lewis A. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol. 2004;25:341-346.
Pinamonti B, Alberti E, Cigalotto A, et al. Echocardiographic findings in myocarditis. Am J Cardiol. 1988;62:285-291.
Angelini A, Calzolari V, Calabrese F, et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart. 2000;84:245-250.
Daubeney P, Nugent AW, Chondros P, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 2006;114:2671-2678.
Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647-1655.
Mendes L, Dec G, Picard M, Palacios I, Newell J, Davidoff R. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am J Heart. 1994;128:301-307.
Gupta S, Markham D, Drazner M, Mammen P. Fulminant myocarditis. Nat Clin Pract Cardiovasc Med. 2008;5:693-706.
Ramachandra G, Shields L, Brown K, Ramnarayan P. The challenges of prompt identification and resuscitation in children with acute fulminant myocarditis: case series and review of the literature. J Paediatr Child Health. 2010;46:579-582.
Foerster SR, Canter CE, Cinar A, et al. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood. Circ Heart Fail. 2010;3:689-769.
McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690-695.
Escher F, Kasner M, Kühl U, et al. New echocardiographic findings correlate with intramyocardial inflammation in endomyocardial biopsies of patients with acute myocarditis and inflammatory cardiomyopathy. Mediators Inflamm. 2013;2013:1-9.
Di Bella G, Coglitore S, Zimbalatti C, et al. Strain Doppler echocardiography can identify longitudinal myocardial dysfunction derived from edema in acute myocarditis. Int J Cardiol 2008;126:279-280.
Friedrich MG, Sechtem U, Schulz-Menger J, et al. International consensus group on cardiovascular magnetic resonance in myocarditis. cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009;53:1475-1487.
Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45:1815-1822.
Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;19:1250-1258.
Jeserich M, Konstantinides S, Pavlik G, Bode C, Geibel A. Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol. 2009;98:753-763.
Miller DD, Holmvang G, Gill JB, et al. MRI detection of myocardial perfusion changes by gadolinium-DTPA infusion during dipyridamole hyperemia. Magn Reson Med. 1989;10:246-255.
Liu P, Mason J. Advances in the understanding of myocarditis. Circulation. 2001;104:1076-1082.
Ferreira V, Schulz-Menger J, Holmvang G, Kramer C, Carbone I, Sechtem U. Cardiovascular magnetic resonance in nonischemic myocardial inflammation. J Am Coll Cardiol. 2018;72:3158-3176.
Wei S, Fu J, Chen L, Yu S. Performance of cardiac magnetic resonance imaging for diagnosis of myocarditis compared with endomyocardial biopsy: a meta-analysis. Med Sci Monit. 2017;23:3687-3696.
Aretz H, Billingham M, Edwards W, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
Braughman K. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:93-595.
Cooper LJ, ElAmm C. Giant cell myocarditis: diagnosis and treatment. Herz. 2012;37:632-636.
Baraldi-Junkins C, Levin H, Kasper E, Rayburn B, Herskowitz A, Baughman K. Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant. 1993;12:63-67.
Sagar S, Liu P, Cooper LJ. Myocarditis. Lancet. 2012;379:738-747.
May L, Patton D, Fruitman D. The evolving approach to paediatric myocarditis: a review of the current literature. Cardiol Young. 2011;21:241-251.
Hunt S, Abraham W, Chin M. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:e391-e479.
Godsel L, Leon J, Engman D. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des. 2003;9:723-735.
Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. J Physiol Heart Circ Physiol. 2004;286:H83-H90.
Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442.
Veeraveedu PT, Watanabe K, Ma M, et al. Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Eur J Pharmacol. 2008;26:121-131.
Veeraveedu PT, Watanabe K, Ma M, et al. Comparative effects of torasemide and furosemide in rats with heart failure. Biochem Pharmacol. 2008;75:649-659.
Xiao J, Shimada M, Liu W, Hu D, Matsumori A. Anti-inflammatory effects of eplerenone on viral myocarditis. Eur J Heart Fail. 2009;11:349-353.
Matsumori A, Igata H, Ono K, et al. High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity. Jpn Circ J. 1999;63:934-940.
Khatib R, Reyes M, Smith F, Khatib G, Rezkalla S. Enhancement of coxsackievirus B4 virulence by indomethacin. J Lab Clin Med. 1990;116:116-120.
Costanzo-Nordin M, Reap E, O'Connell J, Robinson J, Scanlon P. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. J Am Coll Cardiol. 1985;6:1078-1082.
Meune C, Spaulding C, Mahé I, Lebon P, Bergmann J. Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug Saf. 2003;26:975-981.
Zipes D, Camm A, Borggrefe M, et al. College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;1114:e385-e484.
Howlett JG, McKelvie RS, Arnold J, et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol. 2009;25:85-105.
Bradley TD, Holloway RM, McLaughlin PR, Ross BL, Walters J, Liu PP. Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis. 1992;145:377-382.
Sezai A, Hata M, Niino T, et al. Mechanical circulatory support for fulminant myocarditis. Surg Today. 2008;38:773-777.
Drucker NA, Colan SD, Lewis AB, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994;89:252-257.
Bhatt G, Sankar J, Kushwaha K. Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis. Pediatr Cardiol. 2012;33:1370-1376.
McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103:2254-2259.
Gullestad L, Aass H, Fjeld JG, et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation. 2001;103:220-225.
Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. 1989;321:1061-1068.
Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med. 1995;333:269-275.
Kaji M, Kuno H, Turu T, Sato Y, Oizumi K. Elevated serum myosin light chain I in influenza myocarditis. Intern Med. 2001;40:594-597.
Ghelani S, Spaeder M, Pastor W, Spurney C, Klugman D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes. 2012;5:622-627.
Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for the treatment of inflammatory dilated cardiomyopathy. Circulation. 2001;104:639-648.
Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation. 2003;107:857-863.
Frustaci A, Russo M, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009;30:1995-2002.
Miric M, Vasiljevic J, Bojic M, Popovic Z, Keserovic N, Pesic M. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones: initial results. Heart. 1996;75:596-601.
Kuhl U, Pauschinger M, Schwimmbeck P, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003;107:2793-2798.
Hetzer R, Potapov EV, Stiller B, et al. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients. Ann Thorac Surg. 2006;82:917-924.
Fan YE, Weng Y-G, Huebler M, et al. Predictors of in-hospital mortality in children after long-term ventricular assist device insertion. J Am Coll Cardiol. 2011;58:1183-1190.
Barry M, Zipes D. 36th Bethesda Conference: eligibility recommendations for competetive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45:1318-1321.
Maron B, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66:2343-2349.
Gagliardi M, Bassano C, Leonardi B, et al. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart. 2004;90:1167-1171.
Lin M, Tseng Y, Chen M, Chung C, Tsai M, Wang P. In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy. BMC Cardiovasc Disord; 2019;19:10.
Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012;59:1604-1615.
Abrar S, Ansari M, Mittal M, Kushwaha K. Predictors of mortality in paediatric myocarditis. J Clin Diagn Res. 2016;10:SC12-SC16.
Xu D, Zhao R, Gao W, Cui H. A risk prediction model for in-hospital mortality in patients with suspected myocarditis. Chin Med J. 2017;130:782-790.